Genomics Core

Welcome to the Genomics Core of Cleveland Clinic’s Lerner Research Institute (LRI)! Our mission is to provide easy access to state-of-the-art DNA and RNA services to Cleveland Clinic’s investigators and to both external academic and commercial users.

The Genomics Core uses cutting-edge genomics technology to generate top-quality data with a rapid turn-around time and an affordable cost. We offer a wide range of services, including capillary sequencing and genotyping, Illumina microarray-based gene expression profiling and genotyping, and next-generation sequencing (NGS). Our lab is equipped with the renowned Illumina MiSeq desktop sequencer and the Illumina HiSeq2500, which enable rapid and effective targeted and whole genome analyses. We prepare and normalize libraries for RNA-seq, miRNA-seq, DNA-Seq, ChIP-seq, targeted exome sequencing, amplicon sequencing, bacterial 16S metagenomics and whole genome sequencing. Other services include DNA/RNA QC on an Agilent Technologies Bioanalyzer, shearing of DNA and chromatin with Covaris technology, and microarray data analysis support. We also collaborate with the Genomic Medicine Biorepository to extract DNA and RNA for our users.

The Genomics Core team can work with individual users to provide services not listed here. We also provide letters of support for federal and nonfederal grant applications and are open to research collaborations. Please contact Core Manager Dr. Y. Osee Sanogo at sanogoy@ccf.org or (216) 444-7124.

Come visit us in the LRI at:
LRI Genomics Core
Cleveland Clinic
9500 S Euclid Ave/NE5-253
Cleveland, OH 44195
Lab: (216) 444 0974; Office: (216) 444-7124

Yibayiri Osee Sanogo, PhD
Genomics Core Manager

-------------------------
Disclaimer: Data generated by the Genomics Core are for research purposes only. They are not intended or certified for diagnostic or clinical use. All services provided by the Genomics Core should be appropriately acknowledged in scientific publications, posters, and presentations. Furthermore, Core personnel should be recognized as co-authors for substantial intellectual contribution to projects.